Prosthetic heart valves (PHVs) are used to replace diseased native valves among patients with valvular stenosis, incompetence, or both. This paper reviews a number of contemporary prosthetic heart ...
Laplace Interventional announced today that it completed a Series C financing round to support its prosthetic heart valve technology.
Minnesota based Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, ...
Hosted on MSN11d
Medtronic announces two-year trial outcomes of Evolut TAVRAccording to further trial findings, the Evolut TAVR showed a fivefold reduction in prosthetic valve thrombosis and a ...
New class, biomimetic TAVR demonstrates sustained hemodynamic performance to one-yearMINNEAPOLIS and BRISBANE, Australia, March 21, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris® ...
The Prosthetic Heart Valve Market is experiencing significant growth due to the rising prevalence of cardiovascular diseases, increasing elderly population, and advancements in medical technology.
Medtronic (MDT) released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN, SMART, Trial, the largest international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback